These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 11961402
1. The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy. Eiro M, Katoh T, Kuriki M, Asano K, Watanabe K, Watanabe T. Nephron; 2002 Apr; 90(4):432-41. PubMed ID: 11961402 [Abstract] [Full Text] [Related]
2. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system. Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS. Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239 [Abstract] [Full Text] [Related]
3. Renal biopsy findings and clinical indicators of patients with hematuria without overt proteinuria. Hoshino Y, Kaga T, Abe Y, Endo M, Wakai S, Tsuchiya K, Nitta K. Clin Exp Nephrol; 2015 Oct; 19(5):918-24. PubMed ID: 25672293 [Abstract] [Full Text] [Related]
4. Proteinuria in the prognosis of IgA nephropathy. Aucella F, Netti GS, Piemontese M, Cincione IR, Infante B, Gesualdo L. Minerva Urol Nefrol; 2009 Sep; 61(3):235-48. PubMed ID: 19773725 [Abstract] [Full Text] [Related]
6. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF. Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131 [Abstract] [Full Text] [Related]
7. [Importance of the duration from the onset of a urinary abnormality until a biopsy is performed: a multivariate analysis on the application of renal biopsy for patients with IgA nephropathy]. Kiyoshi Y, Hisano S, Takebayashi S. Nihon Jinzo Gakkai Shi; 1998 Sep; 40(7):547-54. PubMed ID: 9805921 [Abstract] [Full Text] [Related]
8. CD147 renal expression as a biomarker for progressive IgAN. Sun S, Zhao A, Li R, Du R, He L, Sun W, Wang H, Huang C. J Nephrol; 2015 Jun; 28(3):307-14. PubMed ID: 25510296 [Abstract] [Full Text] [Related]
11. IgA nephritis: on the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Bogenschütz O, Bohle A, Batz C, Wehrmann M, Pressler H, Kendziorra H, Gärtner HV. Am J Nephrol; 1990 Jun; 10(2):137-47. PubMed ID: 2349957 [Abstract] [Full Text] [Related]
16. [Clinical and pathological analysis of IgA nephropathy with acute kidney injury]. Chen MG, Ye XH, Liang HY, Yang Q. Zhonghua Er Ke Za Zhi; 2016 Aug; 54(8):610-3. PubMed ID: 27510875 [Abstract] [Full Text] [Related]
17. Urine podocyte mRNAs mark disease activity in IgA nephropathy. Fukuda A, Sato Y, Iwakiri T, Komatsu H, Kikuchi M, Kitamura K, Wiggins RC, Fujimoto S. Nephrol Dial Transplant; 2015 Jul; 30(7):1140-50. PubMed ID: 25956757 [Abstract] [Full Text] [Related]
18. Segmental glomerulosclerosis in IgA nephropathy after renal transplantation: relationship with proteinuria and therapeutic response to enalapril. Jeong HJ, Kim YS, Kwon KW, Kim MS, Kim S, Choi KH, Lee HY, Han DS, Park K. Clin Transplant; 2003 Apr; 17(2):108-13. PubMed ID: 12709075 [Abstract] [Full Text] [Related]